FDA OKs Another PD-1 Inhibitor for Merkel Cell Carcinoma
(MedPage Today) -- Credit: Klaus D. Peter, Wiehl, Germany
The second time proved to be the charm for the PD-1 inhibitor retifanlimab (Zynyz), as the FDA approved the drug for Merkel cell carcinoma (MCC).
The agency had previously rejected...
Source: MedPage Today Public Health - Category: American Health Source Type: news